Direct Vasoactive Effects of the Chromogranin A (CHGA) Peptide Catestatin in HumansIn Vivo-Reference-Cited by-同舟云学术

Direct Vasoactive Effects of the Chromogranin A (CHGA) Peptide Catestatin in HumansIn Vivo

Published:2010-07-27 Issue:5 Volume:32 Page:278-287
ISSN:1064-1963
Container-title:Clinical and Experimental Hypertension
language:en
Short-container-title:Clinical and Experimental Hypertension

Author:

Fung Maple M.,Salem Rany M.,Mehtani Parag,Thomas Brenda,Lu Christine F.,Perez Brandon,Rao Fangwen,Stridsberg Mats,Ziegler Michael G.,Mahata Sushil K.,O'Connor Daniel T.

Publisher

Informa UK Limited

Subject

General Medicine,Physiology,Internal Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/10641960903265246

Reference42 articles.

1. Chromogranin A, an “On/Off” Switch Controlling Dense-Core Secretory Granule Biogenesis

2. Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog

3. Chromogranin A in Human Hypertension

4. The Chromogranin–Secretogranin Family

5. Catestatin is a novel endogenous peptide that regulates cardiac function and blood pressure

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vasostatin-1 restores autistic disorders in an idiopathic autism model (BTBR T+ Itpr3tf/J mice) by decreasing hippocampal neuroinflammation;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-12

2. The Role of Catestatin in Preeclampsia;International Journal of Molecular Sciences;2024-02-20

3. Comparison of serum neuropeptide-FF and catestatin levels in hypertensive pregnant women;Annals of Clinical and Analytical Medicine;2024

4. Chromogranin A and its derived peptides: potential regulators of cholesterol homeostasis;Cellular and Molecular Life Sciences;2023-08-29

5. Low catestatin as a risk factor for cardiovascular disease – assessment in patients with adrenal incidentalomas;Frontiers in Endocrinology;2023-07-14